Evidence map›Paper›PMID 31569599›Full record

ReviewInternational journal of molecular sciences2019

SLAM-SAP-Fyn: Old Players with New Roles in iNKT Cell Development and Function.

Devika Bahal, Tanwir Hashem, Kim E Nichols, Rupali Das

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Devika BahalComparative Medicine and Integrative Biology Program, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA. bahaldev@msu.edu.
Tanwir HashemDepartment of Physiology, College of Natural Science, Michigan State University, East Lansing, MI 48824, USA. hashemta@msu.edu.
Kim E NicholsDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. kim.nichols@stjude.org.ORCID 0000-0002-5581-6555
Rupali DasDepartment of Physiology, College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA. dasrupal@msu.edu.
Michigan State University · USSt. Jude Children's Research Hospital · US

Funding

Roles of CD2 and 2B4 in invariant natural killer T (iNKT) cell functions.K22CA188149 · NCI · MICHIGAN STATE UNIVERSITY · PI DAS, RUPALI · 2015 to 2017
$542k
NCI NIH HHS K22 CA188149
6 · The paper itself

Abstract

Invariant natural killer T (iNKT) cells are a unique T cell lineage that develop in the thymus and emerge with a memory-like phenotype. Accordingly, following antigenic stimulation, they can rapidly produce copious amounts of Th1 and Th2 cytokines and mediate activation of several immune cells. Thus, it is not surprising that iNKT cells play diverse roles in a broad range of diseases. Given their pivotal roles in host immunity, it is crucial that we understand the mechanisms that govern iNKT cell development and effector functions. Over the last two decades, several studies have contributed to the current knowledge of iNKT cell biology and activity. Collectively, these studies reveal that the thymic development of iNKT cells, their lineage expansion, and functional properties are tightly regulated by a complex network of transcription factors and signaling molecules. While prior studies have clearly established the importance of the SLAM-SAP-Fyn signaling axis in iNKT cell ontogenesis, recent studies provide exciting mechanistic insights into the role of this signaling cascade in iNKT cell development, lineage fate decisions, and functions. Here we summarize the previous literature and discuss the more recent studies that guide our understanding of iNKT cell development and functional responses.

Indexed as

Signal TransductionAnimalsBiomarkersCell DifferentiationClonal Selection, Antigen-MediatedHumansNatural Killer T-CellsPhenotypeProtein BindingProto-Oncogene Proteins c-fynSignaling Lymphocytic Activation Molecule Associated ProteinSignaling Lymphocytic Activation Molecule FamilyBiomarkersProto-Oncogene Proteins c-fynSignaling Lymphocytic Activation Molecule Associated ProteinSignaling Lymphocytic Activation Molecule Familyantitumor responsecell fatecytokineFynlineage developmentnatural killer T cellssignaling lymphocyte activation molecule (SLAM)SLAM-associated proteintranscription factors

Identifiers

PMID31569599
PMCPMC6801923
OpenAlexW2975672372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.